3 rd &nbsp;Drug Discovery Re-Invented Conference

Report

The third Drug Discovery Re-Invented Meeting focused on the science, structure, and business of drug discovery today with an emphasis on how it is being accomplished outside the traditional large pharmaceutical company model. The meeting brought together experts in medicinal chemistry, biology, structure-based drug design, computational chemistry, novel technology platforms, and natural products discovery.

The meeting was chaired by William Kinney (President, IteraMed Consulting LLC), Charles Reynolds (President, Gfree Bio LLC), Cedric Pearce (CEO/CSO, Mycosynthetix), and Christopher Cooper (Senior Director of Chemistry, TB Alliance).

Day 1 started with a Keynote Address, delivered by Ted Torphy (CSO, BioMotiv). This very informative analysis of the changing drug discovery landscape was titled “In Theory, the Model is Brilliant – Learnings from the Harrington Project, a New Disruptive Model of R&D.” Ted’s talk set the tone for the meeting. Day 1 continued with the “New Approaches in Biotech, Pharma, and Academia” session with talks from Guy Breitenbucher (Dart NeuroScience), Bob Wenslow (Crystal Pharmatech), Kevin Madauss (GlaxoSmithKline), Jose Fenandez (Signum Biosciences), Garry Smith (Fox Chase Chemical Diversity Center), and Stephen Martin (University of Texas at Austin). Important topics for discussion included fatty acid amide hydrolase inhibitors; the importance of defining crystalline forms in early development; an alternative discovery and development model in Latin America; developing novel technologies spanning opportunities in dermatology and neurology; development of small molecules to treat Epstein-Barr virus associated diseases; and applications of chemistry to unmet needs in neuroscience.

Day 2, the international AM session on “Natural Products” was chaired by Cedric Pearce who emphasized the medical and commercial impact of natural products such as Taxol and the Statins. The session included presentations by Nicholas Oberlies (University of North Carolina at Greensboro), Roberto Berlinck (Instituto de Quimica de São Carlos), Jose Medina-Franco (Universidad Nacional Autonoma de Mexico), Guy Carter (Carter-Berman Consulting), Mark Hamann (Medical University of South Carolina), Ronald Quinn (Griffith University) and Andreas Vilcinkas (Univeristy of Gießen). Highlights included the delivery of hydrophobic natural products by pH release from nanoparticles; progress on leishmaniasis and chagas disease in Brazil; methods of defining diversity in natural products; fungal metabolites; algae derived natural products; fragment based discovery using natural products; and gram negative antibiotics from insects. The PM session on “Non-profit Drug Discovery” was chaired by Christopher Cooper and featured Peter Warner (Bill and Melinda Gates Foundation), Leah Frye (Schrödinger), Jeremy Burrows (MMV), Manu De Rycker (University of Dundee), Barry Bunin (Collaborative Drug Discovery), and Christopher Cooper (TB Alliance). The non-profit session was focused on the diseases of the developing world including malaria, river blindness, tuberculosis, and new structure-based methods using water mapping and FEP.

On Day 3, the “Structure, Modeling, and Fragment-Based Design” session started with one of the pioneers in fragment-based design, Dagmar Ringe (Brandeis). Her talk was followed by Bill Jorgensen (Yale), John Kulp (Connifer Point), Chuck Reynolds (Gfree Bio), Matt Segall (Optibrium), and Sandor Vajda (Boston University). Highlights included research in Alzheimers disease targeting Vacuolar Protein Sorting Gene that controls trafficking of proteins to the lysosome; in cancer by modulation of Macrophage Migration Inhibitory Factor; in a user friendly, affordable and powerful web-based fragment based drug design platform; in the importance of ligand efficiency factoring in the size of the target protein; a powerful database analysis tool; in web-based informatics innovations; and in hot spot analysis for druggability and fragment binding. This session was followed by a group snorkeling trip through a well preserved coral marine park.

The day continued with a session on “New Tools and Technologies” that featured lectures by lead snorkeler Rachel Garlish (UCB), Andrea Reid (Dechert LLP), and Janet Ralbovsky (Dana-Farber Cancer Institute). Important topics included native and hydrogen deuterium MS techniques for evaluating interactions of small molecules with their target proteins; recent developments in court cases on “obviousness” when determining the patentability of new discoveries; and the interface between drug discovery and commercialization at the Dana-Farber Cancer Institute. This session was followed by the poster session and a very popular breakout discussion with acclaimed patent attorney Andrea Reid.

Day 4, “Non-Traditional Targets and Approaches” continued with presentations by Scott Dax (BioMotiv), Barte DeCorte (Kodib), and one of the student travel award winners, Chao Wang (Griffith Institute for Drug Discovery). Presentations included a peroxynitrite quenching molecule for the treatment of inflammatory pain that also helps with opiate tolerance and is opiate sparing; and the power of novel chemical space derived from natural products combined with diverse phenotypic model systems.

The meeting was extremely interactive with enthusiastic question and answer sessions following each talk (so much so it was hard to stay on time). This meeting remains unique with respect to the breadth of participants and focus on new approaches to discovering drugs.

Supported By

Media Partners

If you're interested in sponsoring this conference please contact us.

3^rd Drug Discovery Re-Invented Conference

Emerging Role of Biotechs, Academics and Non-Profits

21 Feb 2017 - 24 Feb 2017

Cancun, Mexico

Chairs

Synopsis

The third Drug Discovery Re-Invented Fusion series will center on new approaches to drug discovery in an industry where the landscape is changing rapidly. With large pharma reducing investment in internal early stage research, drug pipelines will increasingly be filled by alternative sources. These players include: government, academic labs, non-profits, biotech companies, and pharmaceutical “open innovation” models. The conference will also provide examples of successful strategies for advancing new drug candidates in this era of distributed discovery.

Key Sessions

New Approaches in Biotech and Academia
New Approaches in Pharma
Natural Products
Government and Non-profit Sector in Drug Discovery and Development
Structure, Modeling, and Fragment-based Design
Non-traditional targets and approaches
Industry Exhibit

Chair Biographies

Dr. William A. Kinney's Bio

Dr. Kinney began his industrial career in the CNS group at Wyeth, where he invented the unique NMDA antagonist perzinfotel that progressed to phase II clinical trials for pain. At Magainin Pharmaceuticals, he was an inventor of trodusquemine (phase II, obesity) and squalamine (phase II, eye disease), two shark-derived natural products; and led their development from a CMC perspective. In 2000, he joined Johnson & Johnson, where he pursued peptide-mimetic integrin antagonists and urotensin-II receptor modulators for cardiovascular indications. He also made seminal discoveries with respect to self-assembling collagen-mimetic peptides that stimulate platelet aggregation. Currently, Dr. Kinney is a faculty member within the Baruch S. Blumberg Institute (BSBI) and directs the Natural Product Discovery Institute (NPDI) that houses the former Merck Research Laboratories Natural Product Collection. He is an adjunct faculty member at Drexel University and Founder of IteraMed, a company focused on medicinal chemistry, drug discovery, and small business development. Dr. Kinney co-founded Revive Genomics INC, which will map out the genomic potential of the actinomycete collections. Revive Genomics was established to apply new genomic technologies to discover novel natural products of use in pharmaceutical and agricultural industries. Dr. Kinney’s scientific contributions include 70 publications, invited lectures, and oral presentations and inventorship on 39 issued U.S. patents.

Dr. Charles H. Reynolds' Bio

Dr. Reynolds is Founder of GFree, Bio (www.gfreebio.com), a structure-based design and modeling company. He is an expert in the areas of computational chemistry, structure-based design, and drug discovery with a broad range of experience. Dr. Reynolds is also a Director on the Advisory Board of Quantum Bio and an adjunct professor at the Pennsylvania Drug Discovery Institute. Previously he was Senior Director and Head of Discovery Technologies at Ansaris (Locus). Prior to joining Ansaris, he led modeling groups at the Springhouse, PA and La Jolla, CA research sites of Johnson & Johnson and was a Research Fellow at Rohm and Haas (now Dow). He is a Fellow of the American Chemical Society, sits on the ACS publications committee, and is a member of the EAB for ACS Medicinal Chemistry Letters. Dr. Reynolds earned a BA, with honors, from Austin College and PhD from the University of Texas at Austin. He has published approximately 100 papers, patents, and book chapters, and is a co-editor of two books. His comments on drug discovery have been sought by news organizations ranging from C&E News to the Wall Street Journal.

Session Chairs

Non-Profit Research: Dr. Christopher Cooper

Dr. Cooper received his BS (magna cum laude) in Chemistry from Clemson University in 1980, and his MS in Organic Chemistry at Stanford University with Professor Carl Djerassi in 1982. Following a two-year industry sabbatical at CIBA-Geigy Pharmaceuticals (now Novartis), he returned to Stanford in 1984 to earn his Ph.D. in Organic Chemistry with Professor Paul A. Wender. From 1988 through 1998, Dr. Cooper was engaged in medicinal chemistry research at Pfizer, Inc., at both their Groton, Connecticut, and Sandwich, England, laboratories. In 1998, Dr. Cooper accepted a position with Bristol-Myers Squibb, Inc., in Princeton, New Jersey, to launch the Lead Synthesis Group (Early Discovery Chemistry), and to oversee the design, development, and synthesis of novel, drug-like medicinal chemistry arrays. Dr. Cooper joined the Global Alliance for TB Drug Development (TB Alliance) in January, 2009, and is currently serving as Senior Director, Chemistry. His responsibilities include direction of all lead identification, lead optimization, pre-clinical and clinical candidate chemistry efforts across TB Alliance’s drug discovery portfolio. Dr. Cooper has over 60 publications, presentations, and patents, and he currently serves on the scientific advisory boards for Anacor Pharmaceuticals/Bill and Melinda Gates Foundation, Eli Lilly TB Drug Discovery Initiative, Weill Cornell Medical Center TB Research Unit, and the Maurice Wilkins Centre for Molecular Biodiscovery [New Zealand].

Natural Products: Dr. Cedric Pearce

Cedric Pearce obtained B.Sc. and Ph.D. degrees from the University of Southampton, UK. His current major interest is new drug discovery and development, and entrepreneurship in the life sciences. Following post-doctoral appointments in France (Royal Society European Exchange Fellow at C.N.R.S.) and the University of Illinois at Urbana/Champaign (School of Chemical Sciences), he was a faculty member in the Department of Medicinal Chemistry and Pharmacognosy at the University of Connecticut. In the 1990s he joined American Cyanamid’s medical and agricultural natural products discovery program and since that time has worked in the biotechnology industry, both as a scientist and from the investment perspective. In 2001 he founded Mycosynthetix Inc. a fungus metabolites research company. Mycosynthetix has been involved with the discovery and development of biologically-active fungal metabolites for a variety of applications, and currently has projects in the fields of agriculture (including the development of the herbicide, mevalocidin), cancer, and infectious diseases (including a project to find new medicines for the free-living parasitic amoebae Naegleria fowleri, funded by NIAID). He has (co)authored >200 publications, patents, chapters and conference abstracts, with approximately half addressing biologically-active fungal products and half addressing bacterial products, largely antibiotics . He is an editor for the Journal of Natural Products and MYCOSCIENCE. He is currently Vice President (and, in 2017, President) of the American Society of Pharmacognosy, a leading natural products research society.

Confirmed Speakers

Roberto Berlinck (Instituto de Química de São Carlos)
Guy Breitenbucher (Dart NeuroScience)
Barry Bunin (Collaborative Drug Discovery)
Jeremy Burrows (MMV)
Guy Carter (Carter-Bernan Consulting)
Christopher Cooper (TB Alliance)
Scott Dax (BioMotiv)
Bart Decorte (Kodib)
Manu De Rycker (University of Dundee)
Jose Fernandez (Signum Biosciences )
Leah Frye (Schrödinger)
Rachel Garlish (UCB)
Mark Hamann (Medical University of South Carolina)
William Jorgensen (Yale University)
John Kulp (Blumberg Institute)
Kevin Madauss (GSK)
Stephen Martin (University of Texas at Austin)
Jose Medina (Universidad Nacional Autonoma de Mexico)
Nicholas Oberlies (The University of North Carolina at Greensboro)
Cedric Pearce (Mycosynthetix)
Ronald Quinn (Griffith University)
Janet Ralbovsky (Dana-Farber Cancer Institute)
Andrea L.C. Reid (Dechert LLP)
Dagmar Ringe (Brandeis University)
Matthew Segall (Optibrium)
Garry Smith (Fox Chase Chemical Diversity Center)
Ted Torphy (Biomotiv)
Sandor Vajda (Boston University)
Peter Warner (Bill and Melinda Gates Foundation)
Bob Wenslow (Crystal Pharmatech)

Supported By

Media Partners

If you're interested in sponsoring this conference please contact us.

3^rd Drug Discovery Re-Invented Conference

Emerging Role of Biotechs, Academics and Non-Profits

21 Feb 2017 - 24 Feb 2017

Cancun, Mexico

Chairs

Speakers

Invited Speakers

Stephen Martin

Professor, The University of Texas

Theodore Torphy

Chief Science Officer, BioMotiv LLC

Roberto G. S. Berlinck

Full Professor, Universidade de SÃ£o Paulo

Robert Wenslow

VP Business Development, Crystal Pharmatech, INC

William Jorgensen

Sterling Professor, Yale University

Andrea Reid

Partner, Patent Counseling and Prosecution, Dechert LLP

Leah Frye

Vice President, Schrodinger

Scott Dax

Project Director, BioMotiv

Janet Ralbovsky

Sr. Licensing Associate, Dana-Farber Cancer Institute

Guy Carter

Chief Scientific Officer, Biosortia Pharmaceuticals

Matthew Segall

CEO, Optibrium Ltd

Kevin Madauss

Programme Manager: Trust in Science, GlaxoSmithKline

Jose Medina-Franco

Professor, Universidad Nacional Autonoma de Mexico

Peter Warner

Senior Prorgam Officer, Bill & Melinda Gates Foundation

Ronald Quinn

Professor, Griffith University

Barry Bunin

CEO, Collaborative Drug Discovery

Mark Hamann

Professor of Drug Discovery and Biomedical Sciences, MUSC

Dagmar Ringe

professor, Brandeis Univiversity

Manu De Rycker

Portfolio Leader Kinetoplastids, University of Dundee

John Kulp

CEO, Conifer Point

Rachel Garlish

Senior Principle Scientist, UCB

Jeremy Burrows

VP, Head of Drug Discovery, Medicines for Malaria Venture

James Breitenbucher

Director of Chemistry, Dart Neuroscience

Bart DeCorte

VP Business Development, Mercachem

Garry Smith

Director of Chemistry, Fox Chase Chemical Diversity Center

Nicholas Oberlies

Professor , UNCG

Jose Fernandez

Director of R&D, Signum Dermalogix, Inc.

Supported By

Media Partners

If you're interested in sponsoring this conference please contact us.

3^rd Drug Discovery Re-Invented Conference

Emerging Role of Biotechs, Academics and Non-Profits

21 Feb 2017 - 24 Feb 2017

Cancun, Mexico

Chairs

Programme

TUESDAY 21^ST FEBRUARY 2017
13:15 – 14:15	Registration & Reception
13:15 – 14:15	Welcome Lunch Kalmia Buffet Restaurant
14:15 – 14:30	Opening Comments
NEW APPROACHES IN BIOTECH AND ACADEMIA Session Chair: Chuck Reynolds, Gfree Bio
14:30 – 15:15	Ted Torphy Biomotiv	“IN THEORY, THE MODEL IS BRILLIANT” – LEARNINGS FROM THE HARRINGTON PROJECT, A NEW DISTRIBUTIVE MODEL OF R&D
15:15 – 15:45	Guy Breitenbucher Dart NeuroScience	REFLECTING ON FATTY ACID AMIDE HYDROLASE (FAAH): A LOOK BACK AT A SUCCESSFUL ACADEMIC-INDUSTRIAL COLLABORATION IN DRUG DISCOVERY
15:45 – 16:15	Bob Wenslow Crystal Pharmatech	DON’T OVERLOOK KEY PRECLINICAL RESEARCH IN EARLY PHARMACEUTICAL DEVELOPMENT
16:15 – 16:45	Refreshments
NEW APPROACHES IN BIOTECH AND ACADEMIA Session Chair: William Kinney, IteraMed Consulting
16:45 – 17:15	Kevin Madauss GlaxoSmithKline	GSK’s TRUST IN SCIENCE PROGRAM: AN ALTERNATIVE DISCOVERY AND DEVELOPMENT MODEL IN LATIN AMERICA
17:15 – 17:45	Jose Fernandez Signum Biosciences	FROM CONSUMER PRODUCTS TO DRUGS: DEVELOPING NOVEL TECHNOLOGIES IN DERMATOLOGY AND NEUROLOGY
17:45 – 18:15	Garry Smith Fox Chase Chemical Diversity Center	DRUG DISCOVERY AT THE ACADEMIC/BIOTECH START-UP INTERFACE: DEVELOPMENT OF SMALL MOLECULES TO TREAT EPSTEIN-BARR VIRUS-ASSOCIATED DISEASES, CONTINUED
18:15 – 18:45	Stephen Martin University of Texas at Austin	APPLICATIONS OF CHEMISTRY TO UNMET MEDICAL NEEDS IN NEUROSCIENCE
18:45	Dinner at Leisure & Free Time

WEDNESDAY 22^ND FEBRUARY 2017
07:00 – 08:15	Breakfast Kalmia Buffet Restaurant
NATURAL PRODUCTS SESSION Session Chair: Cedric Pearce, Mycosynthetix
08:15 – 08:30	Cedric Pearce Mycosynthetix	INTRODUCTORY COMMENTS
08:30 – 09:15	Nicholas Oberlies The University of North Carolina at Greensboro	ANTICANCER DRUG LEADS FROM NATURAL SOURCES: STRATEGIES, PROGRESS, AND INNOVATIVE TECHNIQUES
09:15 – 09:45	Roberto Berlinck Instituto de Química de São Carlos	DISCOVERY AND SAR INVESTIGATIONS OF ANTI-PARASITIC ALKALOIDS
09:45 – 10:15	Jose Medina Universidad Nacional Autonoma de Mexico	CHEMINFORMATICS ANALYSIS OF THE CHEMICAL SPACE OF NATURAL PRODUCTS FOR DRUG DISCOVERY
10:15 – 10:45	Refreshments & Group Photo
10:45 – 11:15	Guy Carter Carter-Bernan Consulting	LEVERAGING THE CHEMICAL DIVERSITY OF AQUATIC MICROBIOMES
11:15 – 11:45	Mark Hamann Medical University of South Carolina	NUISANCE AND HARMFUL ALGAL BLOOMS: AN EMERGING SOURCE FOR DRUG DISCOVERY AND DEVELOPMENT
11:45 –12:15	Ronald Quinn Griffith University	FRAGMENT-BASED DRUG DISCOVERY USING NATURAL PRODUCTS
12:15 –12:45	Andreas Vilcinskas Fraunhofer IME	THE SANOFI-FRAUNHOFER CENTER FOR NAURAL PRODUCT RESEARCH
12:45 – 16:15	Lunch at Leisure & Free Time
NON-PROFIT SECTOR IN DRUG DISCOVERY AND DEVELOPMENT Session Chair: Christopher Cooper, TB Alliance
16:15 – 16:45	Peter Warner Bill and Melinda Gates Foundation	DRUG DISCOVERY FOR NEGLECTED DISEASES: IMPORTANCE OF PARTNERSHIPS
16:45 – 17:15	Leah Frye Schrödinger	STRUCTURE-BASED DRUG DISCOVERY IN THE NON-PROFIT SECTOR
17:15 – 17:45	Jeremy Burrows MMV	DRUG DISCOVERY TO CONTROL AND ERADICATE MALARIA
17:45 – 18:15	Refreshments
18:15 – 18:45	Manu De Rycker Drug Discovery Unit, University of Dundee	DISCOVERY AND LEAD-OPTIMISATION OF A PROMISING NEW ANTILEISHMANIAL COMPOUND SERIES WITHIN AN ACADEMIC-INDUSTRY PARTNERSHIP
18:45 – 19:15	Barry Bunin Collaborative Drug Discovery	PRESENT AND FUTURE COLLABORATIVE DRUG DISCOVERY INFORMATICS INNOVATIONS
19:15 – 19:45	Christopher B. Cooper TB Alliance	ANTITUBERCULAR 3-(4-AMINOPHENYL)OXAZOLIDIN-2-ONES: PROGRESS TOWARDS BETTER, SAFER TB AGENTS
19:45	Dinner at Leisure & Free Time

THURSDAY 23^RD FEBRUARY 2017
07:00 – 08:30	Breakfast Kalmia Buffet Restaurant
STRUCTURE, MODELING, AND FRAGMENT-BASED DESIGN SESSION Session Chair: Chuck Reynolds, Gfree Bio
08:30 – 09:00	Dagmar Ringe Brandeis	CHEMICAL CHAPERONES AS AN APPROACH TO TREAMENT OF ALZHEIMER’S DISEASE
09:00 – 09:30	Bill Jorgensen Yale	COMPUTER-AIDED DISCOVERY OF ENZYME INHIBITORS
09:30 – 10:00	John Kulp Conifer Point	AN OPEN WEB SERVICE FOR FRAGMENT-BASED DESIGN OF SMALL MOLECULES
10:00 – 10:30	Refreshments
10:30 – 11:00	Chuck Reynolds Gfree Bio	RETHINKING LIGAND EFFICIENCY
11:00 – 11:30	Matt Segall Optibrium	SEAMLESS INTEGRATION OF 3D STRUCTURE-BASED DESIGN AND 2D STRUCTURE-ACTIVITY RELATIONSHIPS TO GUIDE MEDICINAL CHEMISTRY
11:30 – 12:00	Sandor Vajda Boston University	HOT SPOT ANALYSIS FOR DRUGGABILITY AND FRAGMENT BINDING
12:00 – 16:00	Lunch at Leisure & Free Time
DRUG DISCOVERY AND DEVELOPMENT TOOLS AND TECHNOLOGIES Session Chair: Bill Kinney, IteraMed Consulting
16:00 – 16:30	Rachel Garlish UCB	NATIVE AND HYDROGEN DEUTERIUM MASS SPECTROMETRY IN DRUG DISCOVERY
16:30 – 17:00	Andrea L.C. Reid Dechert LLP	FOUNDATIONS OF PATENT LAW: OBVIOUSNESS
17:00 – 17:30	Janet Ralbovsky Dana-Farber Cancer Institute	DRUG DISCOVERY AND COMMERCIALIZATION AT THE DANA-FARBER CANCER INSTITUTE
17:30 – 17:50	Martina Sutovska Comenius University and BioMed	ECHINACEA PURPUREA - A SOURCE OF GLYCOCONJUGATE WITH BRONCHODILATING AND ANTI-INFLAMMATORY EFFECTS
17:50 – 19:00	Poster Session & Refreshments
17:50 – 19:00	Andrea Reid (Dechert LLP) IP Breakout Session
19:30	Gala Dinner & Poster Awards

FRIDAY 24^TH FEBRUARY 2017
07:00 – 08:30	Breakfast Kalmia Buffet Restaurant
NON-TRADITIONAL TARGETS AND APPROACHES Session Chair: Chuck Reynolds, Gfree Bio
08:30 – 09:00	Scott Dax BioMotiv	PHENOTYPIC SCREENING AND ANTI-OXIDANT ASSAYS LEADING TO THE DISCOVERY OF A NOVEL CLASS OF ANALGESICS
09:00 – 09:30	Bart DeCorte Kodib	NATURAL-PRODUCT DERIVED NOVEL CHEMICAL SPACE – A POWERFUL STARTING POINT IN DRUG DISCOVERY
STUDENT PRESENTATIONS Session Chair: Bill Kinney, IteraMed Consulting
09:30 – 09:50	Chao Wang Griffith Institute for Drug Discovery	MEET THE CHALLENGE: PROBING PARKINSON’S DISEASE BIOLOGY BY INTEGRATED MULTIDISCIPLINARY METHODOLOGY
09:50 – 10:10	Xioayan Chen Medical University of South Carolina	EXPLORATION OF DRUG LEADS FROM THE HUMAN MICROBIOME: AKKERMANSIA MUCINIPHILA
10:10 – 10:25	Closing Comments

Supported By

Media Partners

If you're interested in sponsoring this conference please contact us.

3^rd Drug Discovery Re-Invented Conference

Emerging Role of Biotechs, Academics and Non-Profits

21 Feb 2017 - 24 Feb 2017

Cancun, Mexico

Chairs

Prices

Ticket Type	Early Bird	Full Price
Single Choose this option if you will be attending the conference alone, or if you will bring accompanying guests that will not attend the meeting.	$1533	$1633
Shared Choose this option if you wish to share with a colleague who is also attending the conference, or if you wish to be paired with another attendee of the same sex.	$1533	$1633
Student Choose this option if you are a student. Please note all students will be paired with another attendee of the same sex if a room sharer is not specified. If you wish to have your own room, please register under the Single option.	$1236	$1336

Additional Person

This is the cost for an additional adult or child to join you in the same room, for the entire conference period. Accompanying persons are not permitted access to the conference. If you wish to extend your stay, please see our 'Extra night' prices.

Adult

$666

Child

$284

Extra nights

Prices are per person.

Adult

$278

Child

$71

All registration fees include 3 nights accommodation and meals during the conference period. Exact inclusions are detailed below.

Accompanying child fees and extra night child fees are applicable for children aged 5-12 years of age. Children aged 13 years and older are classified as an adult at this venue (Fiesta Americana Condesa).

What's Included in our Registration Fees?

The Fiesta Americana Condesa, Cancun offers a 24hour all inclusive service. Our registration and additional adult/child fees are inclusive of the following;

- Accommodation for 3 Nights (21, 22, 23 February 2017).
- Breakfast, Lunch and Dinner – available at all restaurants according to operational hours or programmed events.
- International Bar available by the glass in restaurants and bars according to operational hours.
- Pool snacks and International Bar available by the glass at Pool Area.
- Minibar including: soft drinks, domestic beer, bottled water and coffee. Refreshed daily.
- 24 Hour Room Service.
- In Room amenity – Bottle of wine, per room, per stay.
- Gala Night Entry (includes an open bar).
- Complimentary WI-FI throughout the hotel.

Additional nights (per person) are inclusive of the following;

- Accommodation for 1 Night
- Lunch on day of arrival
- Dinner on day of arrival
- Breakfast on day of departure
- International bar available by the glass in restaurants and bars from lunch on day of arrival until breakfast on day of departure

Supported By

Media Partners

If you're interested in sponsoring this conference please contact us.

3^rd Drug Discovery Re-Invented Conference

Emerging Role of Biotechs, Academics and Non-Profits

21 Feb 2017 - 24 Feb 2017

Cancun, Mexico

Chairs

Grants

3^rd Drug Discovery Re-Invented Conference

Emerging Role of Biotechs, Academics and Non-Profits

21 Feb 2017 - 24 Feb 2017

Cancun, Mexico

Chairs

Supported By

Media Partners

If you're interested in sponsoring this conference please contact us.

3^rd Drug Discovery Re-Invented Conference

Emerging Role of Biotechs, Academics and Non-Profits

21 Feb 2017 - 24 Feb 2017

Cancun, Mexico

Chairs

Venue

Fiesta Americana Condesa

This stylish hotel features contemporary Mexican architecture, including one of the largest and most impressive thatched-roof "palapas" in the entire country. There are cultural activities, arts and crafts and sports programs to keep you constantly entertained, plus time to relax and enjoy the Mayan culture, soak up the Caribbean sunshine and revel in the international ambiance that settles in after the sun goes down.

Throughout your stay delegates will enjoy a full meal plan, inclusive of beverages. Take your pick from the aromatic Asian delights at Kaumbu, traditional fare at El Mexicano, delicious international cuisine at Kalmia Buffet or perhaps sample the sumptuous Italian dishes at Rosato. There are also several other dining opportunities such as the Cevichería, Pizzeria, Sushi Corner, pool and lounge bar areas. The Gala Night with either a Mayan or Caribbean theme takes place on the third evening of the conference with a mouth-watering feast of local cuisine, an open bar and amazing local entertainment. We welcome all delegates and their accompanying persons to the Gala Night – a truly fun filled night not to be missed!

Hotel Facilities

Lagoon Pool
Extensive Health Club and Spa
Complimentary Wi-Fi in guest rooms and throughout hotel and conference areas

The Fiesta Americana Condesa, Cancun is the 2015 Winner of the Trip Advisor Certificate of Excellence and also received the Travellers Choice Award in 2014.

The remains of ancient Mayan cities are scattered throughout the Yucatan Peninsula and no trip to Cancun would be complete without a visit to these majestic temples and pyramids set amongst lush tropical vegetation. We will be working very closely with a reputable tour company who will be organising trips to Tulum, Chichen Itza, Coba and Xcaret to name a few, some of which may require a full day. Full day excursions will be arranged pre or post conference and may be on an individual or group booking so we would recommend booking extra nights to extend your stay as early as possible to avoid disappointment should these excursions be of interest to you and/or your party. For further information please contact us.

Venue Rating

Currency

US Dollar (USD)

Address

Fiesta Americana Condesa, Blvd.KukulkÃ¡n km 16.5 Zona Hotelera, Cancun, 77500 Mexico

Nearest Airport

Cancun International Airport

Location

Cancun is a delightful combination of natural beauty, islands, ecological reserves and white sandy beaches. However, besides sun, sand and sea, this destination also offers an infinite variety of underwater activities to choose from: the diving, snorkelling and fishing here are outstanding and you will find an undersea world packed with tropical fish that live on the second largest barrier reef in the world. Sports enthusiasts might choose one of the many eco-tourism activities, such as cycling or hiking through the tropical forest or kayaking through mangroves, or something a little more adventuresome, like zip lining through the treetops.

Apart from the more well-known ancient Mayan archealogical sites such as Tulum, Cobá and Chichén Itzá you may like to visit the Aktun Chen caverns, voted one of the Top 10 underwater walks by National Geographic described as a truly magical experience.

Supported By

Media Partners

If you're interested in sponsoring this conference please contact us.

3^rd Drug Discovery Re-Invented Conference

Emerging Role of Biotechs, Academics and Non-Profits

21 Feb 2017 - 24 Feb 2017

Cancun, Mexico

Chairs

Transportation

Cancun International airport is just a short 20 minute journey from the Fiesta Americana Condesa and is easily accessible from almost every country in the world with many major international airlines providing direct or interconnecting flights on a daily basis.

Airport Transfers

Mayan Sky are a reputable and trustworthy DMC based in Cancun. The Mayan Sky team will be on hand to provide a seamless transfer service to and from Cancun International Airport. Mayan Sky will manage and confirm all transportation bookings. To arrange transportation please contact Mayan Sky directly via email, phone or the online booking facility (see links below).

Shuttle Transportation Reservations: http://www.mayansky.com/index.php?fusionconferences2

Private Transportation Reservations: http://www.mayansky.com/index.php?fusionconferences

Conference Shuttle Service

Mayan Sky have arranged a conference shuttle service which will run at scheduled times surrounding our conferences. The conference shuttle schedule can be found below.

Arrivals (Cancun Airport to the Fiesta Americana Condesa)
12:00, 14:00, 15:00, 18:00 and 19:00 hours.

Feb: 20th, 21st, 23rd, 24th, 26th, 27th
Mar: 1st, 2nd, 4th, 5th, 7th, 8th, 10th, 11th, 13th, 14th, 16th, 17th, 19th, 20th

Departures (Fiesta Americana Condesa to Cancun Airport)
12:00, 13:00, 14:00, 15:00 and 18:00 hours.

Feb: 24th, 27th
Mar: 2nd, 5th, 8th, 11th, 14th, 17th, 20th, 23rd

$25 per person, each way (includes taxes)

Please allow at least 45minutes from your flight landing time to the shuttle departure time. In the event of any delays or cancellations, please ensure you contact Mayan Sky at least 24hours in advance; if Mayan Sky are not informed within 24hours full cancellation charges will apply (Not notified of flight cancellation: 100% penalty charge, No-Shows: 100% penalty charge).

Upon arrival at the airport, please exit the terminal building and look for ‘Fusion Conferences’ signage where a member of the Mayan Sky team will greet you and escort you to the group transportation.

Please contact Mayan Sky directly to enquire or make a booking. Please direct enquiries to:

David Garcia (Sales, Groups & Marketing Manager)
Telephone: 521 (998) 301 51 58
Email: gventas@mayanskydmc.com

Shuttle Transportation Reservations: http://www.mayansky.com/index.php?fusionconferences2

Private Transportation

Mayan Sky also offer a private transfer service for those travelling outside of the available shuttle dates/times mentioned above. The private transfer service vehicles can accommodate a maximum of 10 persons, plus luggage.

Private Transportation prices to and from Cancun International Airport and to and from the Fiesta Americana Condesa hotel are as follows:

Unit for 1 or 2 Passengers $40 (one way) / $68 (round trip)
Unit for 3 Passengers $45 (one way) / $75 (round trip)
Unit for 4 Passengers $52 (one way) / $79 (round trip)
Unit for 5 to 10 Passengers $58 (one way) / $90 (round trip)

In the event of any delays or cancellations, please ensure you contact Mayan Sky at least 24hours in advance; if Mayan Sky are not informed within 24hours full cancellation charges will apply (Not notified of flight cancellation: 100% penalty charge, No-Shows: 100% penalty charge).

Upon arrival at the airport, please exit the terminal building and look for ‘Fusion Conferences’ signage where a member of the Mayan Sky team will greet you and escort you to the group transportation.

Please contact Mayan Sky directly to enquire or make a booking. Please direct enquiries to:

David Garcia (Sales, Groups & Marketing Manager)
Telephone: 521 (998) 301 51 58
Email: gventas@mayanskydmc.com

Private Transportation Reservations: http://www.mayansky.com/index.php?fusionconferences

** Please note that Fusion Conferences is not responsible for any bookings made with Mayan Sky as transportation is not included within the registration package **

Supported By

Media Partners

If you're interested in sponsoring this conference please contact us.

3^rd Drug Discovery Re-Invented Conference

Emerging Role of Biotechs, Academics and Non-Profits

21 Feb 2017 - 24 Feb 2017

Cancun, Mexico

Chairs

Local Activities

Half Day Activities

Mayan Sky are a reputable and reliable company offering a variety of fascinating trips and excursions. If you wish to make a booking prior to your arrival, please contact David Garcia at Mayan Sky. If you wish to make a booking onsite at the hotel, please approach the Mayan Sky hospitality desk which will be located alongside the Fusion registration desk.

Please direct enquiries to:
David Garcia (Sales, Groups & Marketing Manager)
Telephone: 521 (998) 301 51 58
Email: gventas@mayanskydmc.com

Our half day tours can be booked during the conference period between the available free times scheduled in the programme. The half day tours are available to both individual and group bookings.

The following activities are available at Aquaworld which is based in the Marina directly opposite the Fiesta Americana Condesa hotel and on the beach, therefore no transportation is necessary.

Aquatwister

Experience Aquaworld’s ultimate tour adventure on board a high speed jet boat ride, Aquatwister. This is a roller coaster of manoeuvres orchestrated by a highly skilled captain and drivers on board and provides an amazing combination of nature, emotion, fun and adrenaline in one adventure.
Duration: 30 minutes

Sky Rider

Live this exciting experience flying in couples above the Caribbean Sea and experience an amazing aerial view.
Duration: 30-40 minutes includes 10 minute flying time at an altitude of 100mtrs

Jungle Tour

The Jungle Tour is considered one of the most popular tours in Cancun. You will enjoy speeding through the dense mangrove channels of the Nichupte Lagoon before snorkelling in the second largest reef barrier in the World.
Duration: 2:15 hrs

Wave Runner

Drive and Speed on board a Yamaha VX 1100 across the Caribbean Sea.
Duration: 30 minutes or 1 hr

Sub See

An extraordinary way to admire the marine life and the reef’s ecosystem without getting wet! Be part of this unique adventure on board The Sub See Explorer, a glass bottom boat from where you will be able to watch the multi-coloured species of the Scorpion´s coral reef.
Duration: 2 hrs.

Fly Board

The Flyboard is the latest craze in water sports sweeping the world, and now you can try it for yourself. Using water jet propulsion from specially designed boot pads, the personal water craft forces water out under extreme pressure sending you soaring into the air to heights of about 5-7 metres.

Full Day Activities

If you wish to make a booking prior to your arrival, please contact David Garcia at Mayan Sky. If you wish to make a booking onsite at the hotel, please approach the Mayan Sky hospitality desk which will be located alongside the Fusion registration desk.

Please direct enquiries to:
David Garcia (Sales, Groups & Marketing Manager)
Telephone: 521 (998) 301 51 58
Email: gventas@mayanskydmc.com

Our full day tours are offered pre and post conference dates. If you require any additional nights at the Fiesta Americana Condesa due to a full day excursion, please ensure you book these in advance to avoid disappointment (through Fusion). The full days tours are available to both individual and group bookings.

Selvatica Extreme Canopy Tour

Over 250 acres of Tropical Jungle, in Selvatica you will be able to experience a unique adventure on the longest zip-line circuit in North America, recognized by Travel & Leisure magazine as one of the 35 great adventures in the World, divided into 12 zip lines varying in lengths and heights from 270 ft. to over 2,000 ft, it will make you fly over the jungle. Then take a ride on a military vehicle through the jungle to get to the natural cenote. With crystal and pristine waters you will be able to swim choosing between a water zip line or the diving platform. Live this unique and exciting adventure and feel the emotion and adrenaline running through your body.

Chichen Itza

Chichen Itza which means “at the mouth of the well of Itza “, is the 2nd most visited archeological site of Mexico today. The Kukulkan Pyramid in Chichen-Itza which known as “El Castillo” (the castle), is one of the new seven wonders of the world elected in 07.07.2007.

Rio Secreto

Rio Secreto is an incredible underground nature reserve on Mexico’s Yucatan Peninsula. Located in the Riviera Maya 3 miles southwest of Playa del Carmen, Rio Secreto is a system of caves carved out over the course of several centuries by an underground river. Stretching approximately 8 miles, with 15 natural outlets, it’s the longest partially flooded cave on Mexico’s Yucatan Peninsula. But what makes Rio Secreto unique is the fact that it’s semi-sunken, which means that you can hike or float through most of it.

Xcaret

Your admission to Xcaret Park allows you to enjoy a natural paradise in Cancun and Riviera Maya, with access to over 40 attractions and activities. We invite you to enjoy a whole day of fun and to assist to cultural events such as the Ritual Ceremony of the Voladores de Papantla, the Mayan Ball Game and the show Xcaret Mexico Espectacular. Dare to live Mexico in Xcaret!

Sail & Snorkel

Enjoy a spectacular day on the crystal clear waters. Sailing from Cancun to Isla Mujeres on board a sailboat. Explore the breath-taking sites of Isla Mujeres one of the wonderful reef in the Caribbean. Join us for a full day of adventure in the most beautiful sea around the world.

Supported By

Media Partners

If you're interested in sponsoring this conference please contact us.

3^rd Drug Discovery Re-Invented Conference

Emerging Role of Biotechs, Academics and Non-Profits

21 Feb 2017 - 24 Feb 2017

Cancun, Mexico

Chairs

Group Activities

We have arranged two exciting group activities for the 2017 DDRI participants. Please find the details, timings and prices for the activities below. One activity is scheduled during conference free time and the second for the day after the meeting.
This is a great opportunity to socialise with fellow colleagues outside of the conference whilst taking in the beautiful natural sights of Cancun.

Snorkel Trip- Wednesday 22^nd February 2017

Departing from Aquaworld marina we take you on a motor boat to "El Meco" marine park. Here you adorn your snorkel gear and you’re ready to take the plunge and snorkel in the crystal clear turquoise waters.

The price per person is $42 USD.
+ $10 USD Marine park/dock fee (to be paid to Aquaworld)

Includes; private boat, snorkel equipment, snorkel guide, 45 minutes for snorkel tour in "El Meco" marine park, water, soda and beers.

Itinerary for Wednesday 22^nd February 2017:
Walk to Aquaworld from hotel- 10/15 minutes (across the road from the hotel)
13:30 – 14:10 Private boat to "El Meco" marine park
14:10 – 14:55 Snorkel tour (45 minutes)
14:55 – 15:35 Private boat return to Aquaworld

*Minimum of 10 people required*

Please note that sign-ups and payment for the trip will need to be made during conference registration at the Mayan Sky Hospitality desk. We will be booking the trip immediately after conference registration.

Mayan Sky will accept both cash and card payments. Please note a surcharge will be added for payments made using card (5% for VISA or Master Card and 6% for AMEX). This is a non-refundable fee should you later change your mind and decide not to participate in the trip.

Chichen Itzá Group Tour – Saturday 25^th February 2017

Discover the essence of the Mayan culture by visiting one of the 7 New Wonders of the World. The visit of Chichen Itza includes a guided tour of 3 hours with time to take pictures. At the end of the tour we go to the restaurant for buffet lunch, followed by the visit of a cenote where people have the possibility to go for a swim.
In addition, when returning to Cancun, we can enjoy a panoramic visit to Valladolid, an ancient Colonial City.

Price: $150 per person

Includes; an air conditioned vehicle, parking, highway fee and tips, entrance/guided tour in the Chichen Itzá archaeological site, entrance and swimming in the Cenote, , visit to Valladolid Colonial City, water, buffet lunch (not including drinks) and a certified Federal Guide.

Itinerary for Saturday 25^th February 2017:
07:00 – 09:30 Trip to Chichen Itzá.
09:40 – 12:40 Tour in Chichen Itzá.
12:50 – 13:00 Trip to Cenote.
13:00 – 14:00 Time in Cenote.
14:10 – 14:20 Transfer to Restaurant.
14:20 – 15:20 Buffet lunch.
15:30 – 16:10 Trip to Valladolid.
16:10 – 17:00 Time in Valladolid.
17:10 – 19:40 Trip to Cancun Hotel Zone.

*Minimum of 8 people required*

Please note that sign-ups and payment for the trip will need to be made during conference registration at the Mayan Sky Hospitality desk. We will be booking the trip immediately after conference registration.

Mayan Sky will accept both cash and card payments. Please note a surcharge will be added for payments made using card (5% for VISA or Master Card and 6% for AMEX). This is a non-refundable fee should you later change your mind and decide not to participate in the tour.

Supported By

Media Partners

If you're interested in sponsoring this conference please contact us.

3^rd Drug Discovery Re-Invented Conference

Emerging Role of Biotechs, Academics and Non-Profits

21 Feb 2017 - 24 Feb 2017

Cancun, Mexico

Chairs

Childcare

Supported By

Media Partners

If you're interested in sponsoring this conference please contact us.

3^rd Drug Discovery Re-Invented Conference

Emerging Role of Biotechs, Academics and Non-Profits

21 Feb 2017 - 24 Feb 2017

Cancun, Mexico

Chairs

Oral Presenters

We have a number of oral opportunities available at this meeting. To be considered for a talk, please register for the conference and you will be able to submit your abstract online and monitor the status of your abstract through your Fusion account. Please use the abstract template provided and ensure your abstract is no longer than one page in length. Any abstracts exceeding this size may be cut short during print.

Please take note of the oral submission deadline: 09 September 2016.

Please check the conference programme carefully to note your presentation time (inclusive of Q&A) should you be accepted for an oral presentation. We recommend you check our website regularly as the conference approaches. Regular programme updates will be released under the ‘Programme’ tab on the conference page.

Your Presentation on the Day

If you have prepared some slides to accompanying your talk please ensure you bring these with you on a USB or portable file saving device.

For those presenting on the first day, please email your slides to us so we can have everything prepared and ready for the first session. Please email your slides to: admin@fusion-conferences.com

On the day of your presentation please make yourself known to the AV team who will be available in the conference room. If you have any animations or videos we do advise to run through the presentation with the AV tech to make sure everything is compatible. We also advise that all speakers make themselves known to the AV tech in the conference room immediately before your session beings. The AV tech will apply your microphone and provide a laser pointer should you have an accompanying presentation. We prefer speakers to use our master laptop to run presentations from, however, if you prefer to use your own laptop, please notify us in advance.

It is important that all speakers adhere to their presentation time and respect their fellow presenters. A visual traffic light aide will be available to warn presenters and the audience as your time decreases.

If you have any questions, please don’t hesitate to approach our AV tech or a member of the Fusion team.

Helpful Tips for Presentation Slides

Aspect Ratio: On Screen Show (16:9) and in Landscape Orientation.
Font Size: Minimum font size used should be 24pt.
File Type: Please safe your presentation in PPT or PPTS format.
Video Clips: Please save these separately and do not build them into the PowerPoint. Videos will be played via the AV control desk using the master laptop.

Download Abstract Template

Supported By

Media Partners

If you're interested in sponsoring this conference please contact us.

3^rd Drug Discovery Re-Invented Conference

Emerging Role of Biotechs, Academics and Non-Profits

21 Feb 2017 - 24 Feb 2017

Cancun, Mexico

Chairs

Posters

We have a number of poster opportunities available at this meeting. To be considered for a poster presentation, please register for the conference and you will be able to submit your abstract online and monitor the status of your abstract through your Fusion account. Please use the abstract template provided and ensure your abstract is no longer than one page in length. Any abstracts exceeding this size may be cut short during print.

Please take note of the poster submission deadline: 09 December 2016

Our poster boards can accommodate a maximum poster size of A0 (1189H x 841W mm), portrait in orientation. Posters exceeding this size may not fit on the poster boards provided and therefore we may be unable to display your poster, so please kindly keep to these measurements.

Displaying & Presenting Your Poster

During conference registration if you are presenting a poster please request a poster number from the registration desk. Please do not put up your poster without notifying a member of the Fusion team. Certain adhesive agents are not permitted at some venues therefore; Fusion will be the sole provider of all poster fixings.

You can display your poster from registration. Your poster can remain on display for the entire duration of the conference and we ask that posters are taken down on the final day of the meeting. The poster session is usually scheduled on Day 3, but please check the official programme for exact timings. Refreshments will be provided and the poster prizes will be awarded during the conference Gala Night that evening.

2017 DDRI Poster Prize

The conference chairs will be awarding 3 poster prizes for the best poster display and presentation. To be in with a chance of winning, submit your poster by 09 December 2016. The winners will be selected shortly after the Poster Session and the following prizes will be awarded. 1st Place $350, 2nd Place $250, 3rd Place $150.

Download Abstract Template

Supported By

Media Partners

If you're interested in sponsoring this conference please contact us.

3^rd Drug Discovery Re-Invented Conference

Emerging Role of Biotechs, Academics and Non-Profits

21 Feb 2017 - 24 Feb 2017

Cancun, Mexico

Chairs

Conference History

16 Oct 2013, 19 Oct 2013

Drug Discovery Re-Invented

Emerging Role of Biotechs, Academics and Non-Profits

Hilton Scottsdale Resort & Villas, Scottsdale, Arizona, USA

The Drug Discovery Re-Invented Fusion conference will center on new approaches to drug discovery in an industry where the landscape is changing rapidly. With large pharma reducing investment in internal early stage research, drug pipelines will in...

09 Aug 2015, 12 Aug 2015

#2 Drug Discovery Re-Invented Conference 2015

Emerging Role of Biotechs, Academics and Non-Profits

Macdonald Berystede Hotel & Spa, Ascot, UK

The second Drug Discovery Re-Invented Fusion series will center on new approaches to drug discovery in an industry where the landscape is changing rapidly. With large pharma reducing investment in internal early stage research, drug pipelines will...

21 Feb 2017, 24 Feb 2017

3^rd Drug Discovery Re-Invented Conference

Emerging Role of Biotechs, Academics and Non-Profits

Fiesta Americana Condesa, Cancun, Mexico

The third Drug Discovery Re-Invented Fusion series will center on new approaches to drug discovery in an industry where the landscape is changing rapidly. With large pharma reducing investment ...

21 Feb 2019, 24 Feb 2019

4^thDrug Discovery Re-Invented Conference

Emerging Role of Biotechs, Academics and Non-Profits

Melia Nassau Beach All Inclusive, Nassau, Bahamas

The fourth Drug Discovery Re-Invented Meeting brings together experts in medicinal chemistry, structure-based drug design, computational chemistry, emerging drug targets, and novel technology platforms. The meeting is extremely interactive with en...

Supported By

Media Partners

If you're interested in sponsoring this conference please contact us.

3^rd Drug Discovery Re-Invented Conference

Emerging Role of Biotechs, Academics and Non-Profits

21 Feb 2017 - 24 Feb 2017

Cancun, Mexico

Chairs